Analysis of tumor response and clinical factors associated with vitiligo in patients receiving anti-programmed cell death-1 therapies for melanoma: A cross-sectional studyCapsule Summary

• Main Authors: Léa Dousset, MD (Author), Alize Pacaud, MD (Author), Thomas Barnetche, PhD (Author), Marie Kostine, MD, PhD (Author), Caroline Dutriaux, MD (Author), Anne Pham-Ledard, MD, PhD (Author), Marie Beylot-Barry, MD, PhD (Author), Emilie Gérard, MD (Author), Sorilla Prey, MD, PhD (Author), Nicolas Andreu, BSc (Author), Katia Boniface, PhD (Author), Julien Seneschal, MD, PhD (Author)
• Format: Book
• Published: Elsevier, 2021-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Clinical factors associated with vitiligo in patients receiving anti-programmed cell death-1 (PD-1) remain unknown. Objective: To better characterize the occurrence of vitiligo in patients receiving anti-PD-1. Methods: The present single-center ambispective cohort study included patients...